Five Years’ Evaluation of the BD ProbeTec System for the direct molecular detection of Mycobacterium tuberculosis complex in respiratory and nonrespiratory clinical samples

• Autorzy: Bicmen C. , Karaman O. , Gunduz A.T. , Erer O.F. , Coskun M. , Kaftan O. , Demirel M.M. , Senol G. , Akarca T. , Dereli S. , Ozsoz A.
• Języki publikacji: EN

Abstrakty

EN

In this study, Mycobacterium tuberculosis complex was detected by BD ProbeTec ET system in 4716 respiratory and 167 nonrespiratory samples [mostly (98%) smear negative]. Sensitivity, specificity, positive and negative predictive values were 81.8%, 98.3, 85.1 and 97.9 for respiratory and 100%, 96.2, 64.7 and 100, for nonrespiratory samples, respectively. Among 149 (3.1%) ProbeTec DTB positive and culture negative samples, 72 (65 respiratory and seven nonrespiratory) (48.3%) were recovered from the patients who were evaluated as having TB infection. The system has been found as useful in early diagnosis of tuberculosis infection in association with the clinical, radiological and histopathological findings.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2015
• Tom: 64
• Numer: 4
• Opis fizyczny: p.391-394,ref.

Twórcy

autor

Bicmen C.

• Medical Microbiology Laboratory, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey

autor

Karaman O.

• Tuberculosis and Chest Diseases Service, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey

autor

Gunduz A.T.

• Medical Microbiology Laboratory, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey

autor

Erer O.F.

• Tuberculosis and Chest Diseases Service, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey

autor

Coskun M.

• Medical Microbiology Laboratory, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey

autor

Kaftan O.

• Medical Microbiology Laboratory, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey

autor

Demirel M.M.

• Medical Microbiology Laboratory, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey

autor

Senol G.

• Medical Microbiology Laboratory, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey

autor

Akarca T.

• Tuberculosis and Chest Diseases Service, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey

autor

Dereli S.

• Tuberculosis and Chest Diseases Service, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey

autor

Ozsoz A.

• Tuberculosis and Chest Diseases Service, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey

Bibliografia

• Abdel-Aziz N.A., K.M. Al-Harbi, M.F. Morsy, K.A. Turkistani and F.N. Kurdi. 2011. Evaluation of direct detection of Mycobacterium tuberculosis in clinical samples using the BD ProbeTec ET system. Saudi Med. J. 32: 123–127.
• Antonenka U., S. Hofmann-Thiel, L. Turaev, A. Esenalieva, M. Abdulloeva, E. Sahalchyk, T. Alnour and H. Hoffmann. 2013. Comparison of Xpert MTB/RIF with ProbeTec ET DTB and COBAS TaqMan MTB for direct detection of M. tuberculosis complex in respiratory specimens. BMC Infect. Dis. 13: 280.
• Barber R. 2008. Evaluation of the BD ProbeTec ET system for the direct detection of Mycobacterium tuberculosis from clinical samples. Br. J. Biomed. Sci. 65: 7–12.
• Barrett A., J.G. Magee and R. Freeman. 2002. An evaluation of the BD ProbeTec ET system for the direct detection of Mycobacterium tuberculosis in respiratory samples. J. Med. Microbiol. 51: 895–898.
• Bergmann J.S. and G.L. Woods. 1998. Clinical evaluation of the BD Probe-Tec strand displacement amplification assay for rapid diagnosis of tuberculosis. J. Clin. Microbiol. 36: 2766–2768.
• Bergmann J.S., W.E. Keating and G.L. Woods. 2000. Clinical evaluation of the BD ProbeTec ET system for rapid detection of Mycobacterium tuberculosis. J. Clin. Microbiol. 38: 863–865.
• Centers for Disease Control and Prevention (CDC). 2009. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR 58: 7–10.
• Gupta R., M. Espinal and Stop TB Working Group on DOTS-Plus for MDR-TB. 2003. A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB). Int. J. Tuberc. Lung. Dis. 7: 410–414.
• Johansen I.S., V.Ø. Thomsen, A. Johansen, P. Andersen and B. Lundgren. 2002. Evaluation of a new commercial assay for diagnosis of pulmonary and non pulmonary tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis. 21: 455–460.
• Karadağ A., E. Usta, K. Bilgin, A.K. Güney, C. Eroğlu and M. Günaydin. 2013. Comparison of culture, Real-Time DNA amplification assay and Ehrlich-Ziehl-Neelsen for detection of Mycobacterium tuberculosis. Balkan Med. J. 30: 13–15.
• Koneman E.W., S.D. Allen, W.M. Janda, P.C. Schreckenberger and W.C Winn (eds). 1992. Mycobacteria, pp. 703–755. In: Color Atlas and Textbook of Diagnostic Microbiology. 4th ed. J.B. Lippincott Company, Philadelphia Pennsylvania.
• Maugein J., J. Fourche, S. Vacher, C. Grimond and C. Bebear. 2002. Evaluation of the BD ProbeTec™ ET DTB assay for direct detection of Mycobacterium tuberculosis complex from clinical samples. Diagn. Microbiol. Infect. Dis. 44: 151–155.
• Mazzarelli G., L. Rindi, P. Piccoli, C. Scarparo, C. Garzelli and E. Tortoli. 2003. Evaluation of the BD ProbeTec ET system for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary samples: a multicenter study. J. Clin. Microbiol. 41: 1779–1782.
• Pfyffer G.E., P. Funke-Kissling, E. Rundler and R. Weber. 1999. Performance characteristics of the BD ProbeTec system for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J. Clin. Microbiol. 37: 137–140.
• Piersimoni C., C. Scarparo, P. Piccoli, A. Rigon, G. Ruggiero, D. Nista and S. Bornigia. 2002. Performance assessment of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex from respiratory and extrapulmonary specimens. J. Clin. Microbiol. 40: 4138–4142.
• Rüsch-Gerdes S. and E. Richter. 2004. Clinical evaluation of the semiautomated BD ProbeTec ET system for the detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. Diagn. Microbiol. Infect. Dis. 48: 265–270.
• Tu H.Z., Y.S. Chen, Y.E. Lin, M.R. Tseng, T.S. Huang, H.C. Tsai and Y.C. Liu. 2011. Combination of molecular assay and clinical evaluation for early confirmation of tuberculosis cases. Clin. Microbiol. Infect. 17: 712–714.
• Wang J.Y., L.N. Lee, C.S. Chou, C.Y. Huang, S.K. Wang, H.C. Lai, P.R. Hsueh and K.T. Luh. 2004. Performance assessment of a nested-PCR assay (the RAPID BAP-MTB) and the BD ProbeTec ET system for detection of Mycobacterium tuberculosis in clinical specimens. J. Clin. Microbiol. 42: 4599–4603.
• Wang J.Y., L.N. Lee, H.L. Hsu, P.R. Hsueh and K.T. Luh. 2006. Performance assessment of the DR. MTBC Screen assay and the BD ProbeTec ET system for direct detection of Mycobacterium tuberculosis in respiratory specimens. J. Clin. Microbiol. 44: 716–719.
• World Health Organization. 1999. What is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS. Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/65979/1/WHO_CDS_CPC_TB_99.270.pdf, 2015.01.14.
• World Health Organization. 2013a. Global Tuberculosis Report. Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf, 2015.01.14.
• World Health Organization. 2013b. Systematic screening for active tuberculosis: Principles and recommendations. Geneva, Switzerland. http://www.who.int/tb/publications/Final_TB_Screening_guidelines.pdf, 2015.01.14.

Identyfikatory

DOI

10.5604/17331331.1185240